FDA official logo
GSRS logoPFDA official logo

ENSOVIBEP

UNII:PV6AA88RDU
Formula:
Preferred Substance Name:ENSOVIBEP

  • 2451126-06-8
  • DESIGNED ANKYRIN REPEAT PROTEIN (SYNTHETIC BIVALENT HUMAN ALBUMIN-BINDING) FUSION PROTEIN WITH DESIGNED ANKYRIN REPEAT PROTEIN (SYNTHETIC TRIVALENT SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR BINDING DOMAIN-BINDING)
  • ENSOVIBEP [INN]
  • ENSOVIBEP [WHO-DD]
  • FUSION PROTEIN CONSISTING OF TWO IDENTICAL ENGINEERED ANKYRIN REPEATS-CONTAINING BINDING PROTEIN DOMAINS ANTI-(HUMAN ALBUMIN) (1-126 FUSED VIA PEPTIDYL LINKER 127GSPTPTPTTPTPTPTTPTPTPT148 TO 149-274), FUSED VIA PEPTIDYL LINKER 275GSPTPTPTTPTPTPTTPTPTPT296 TO THREE ENGINEERED ANKYRIN REPEATS-CONTAINING BINDING PROTEIN DOMAINS ANTI-(THREE DIFFERENT EPITOPES OF THE SARS-COV-2 SPIKE GLYCOPROTEIN) (297-455 FUSED VIA PEPTIDYL LINKER 456GSPTPTPTTPTPTPTTPTPTPT477 TO 478-636 IN TURN FUSED VIA PEPTIDYL LINKER 637GSPTPTPTTPTPTPTTPTPTPT658 TO 659-817)
  • MP0420
  • MP-0420




UNII - PV6AA88RDU | UNII Search Service